Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities

Clinical trial NCT05311709 · UNKNOWN

Trial details

NCT number: NCT05311709
Sponsor: Vestre Viken Hospital Trust
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer NSCLC, Stage III NSCLC Stage IV Lung Cancer Stage IV Mutation Cancer Cancer, Lung

Start date: 2022-05-30
Primary completion: 2024-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.